Flunisolide Nasal Inhalation |
Nasarel; Nasolide (Removed from Market) |
Article: Flunisolide
| Image:Flunisolide.png | |
| Flunisolide | |
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | 3385-03-3 |
| ATC code | R01AD04 R03BA03 |
| PubChem | 82153 |
| DrugBank | APRD00976 |
| Chemical data | |
| Formula | C24H31FO6 |
| Mol. weight | 434.498 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 1.8 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Flunisolide (marketed as AeroBidĀ®, NasalideĀ®, NasarelĀ®) is a corticosteroid often prescribed as treatment for allergic rhinitis.
Categories: Pharmacology stubs | Glucocorticoids

Not Signed In -


